Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Esophageal Cancer, Targeted Therapy, HER2

Yusuf Bhatt

MD

🏢University of Chicago Medicine🌐USA

Associate Professor of GI Oncology

36
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Yusuf Bhatt investigates targeted therapy strategies for esophageal adenocarcinoma and gastroesophageal junction cancers with defined molecular alterations. His research has evaluated HER2-targeted therapy combinations and trastuzumab deruxtecan in HER2-positive esophageal and GEJ cancers. He has examined VEGFR2 inhibition and ramucirumab in treatment sequences for advanced esophageal adenocarcinoma. His translational work aims to molecularly stratify esophageal cancer patients to optimize targeted therapy selection beyond the limited HER2 and PD-L1 biomarkers currently used clinically.

Share:

🧪Research Fields 研究领域

esophageal adenocarcinoma HER2
gastroesophageal junction cancer
trastuzumab esophageal
VEGF inhibitors
molecular targeted therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Yusuf Bhatt 的研究动态

Follow Yusuf Bhatt's research updates

留下邮箱,当我们发布与 Yusuf Bhatt(University of Chicago Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment